Compounds > metronidazole

metronidazole and s 1743

metronidazole has been researched along with s 1743 in 70 studies

Research

Studies (70)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's16 (22.86)29.6817
2010's43 (61.43)24.3611
2020's11 (15.71)2.80

Authors

AuthorsStudies
Lee, J; Machado, S; Veldhuyzen Van Zanten, S1
Bästlein, E; Bayerdörffer, E; Buchner, M; Ebert, S; Haferland, C; Kirsch, C; Lehn, N; Miehlke, S; Neumeyer, M; Schneider-Brachert, W; Stolte, M; Vieth, M1
Johansen, JK; Krogfelt, KA; Ladefoged, K; Myrhøj, T; Sehested, A1
Aponte-Rivera, E; Fernández-Carbia, A; Marxuach-Cuétara, AM; Ríos-Bedoya, CF; Rodríguez-Orengo, JF; Rodríguez-Torres, M; Salgado-Mercado, R1
Pan, Y; Xiao, SD; Zhang, L; Zheng, Q1
Antos, D; Bästlein, E; Bayerdörffer, E; Buchner, M; Haferland, C; Hänel, C; Lehn, N; Meier, E; Schneider-Brachert, W; Stolte, M; Trump, F1
Cheon, JH; Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, DH; Song, IS1
Delitala, G; Dore, MP; Maragkoudakis, E; Pironti, A; Realdi, G; Tadeu, V; Tedde, R1
Bästlein, E; Bayerdörffer, E; Hansky, K; Jacobs, E; Kirsch, C; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Schneider-Brachert, W; Stolte, M1
Alberer, M; Antos, D; Arenz, T; Buderus, S; Kappler, M; Koletzko, S; Rüssmann, H1
Cammarota, G; Candelli, M; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Spada, C; Zocco, MA1
Chen, A; Hsu, PI; Lai, KH; Lo, GH; Tsay, FW; Tseng, HH; Wang, WM; Wu, CJ; Wu, DC; Wu, IC; Wu, JY1
Hassoun, A; Ibrahim, F1
Jung, HC; Kang, JM; Kim, JS; Kim, N; Kim, YR; Lee, DH; Park, YS; Song, IS1
Bästlein, E; Haferland, C; Jebens, C; Kirsch, C; Knoth, H; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Schneider-Brachert, W; Stolte, M; Zekorn, C1
Chang, LL; Chen, A; Hsu, PI; Hu, HM; Jan, CM; Kuo, CH; Kuo, FC; Li, CJ; Tsai, PY; Wang, SW; Wang, WM; Weng, BC; Wu, DC; Wu, IC; Yu, FJ1
Hwang, JH; Hwang, TJ; Jeong, SH; Jung, HC; Kim, JW; Kim, N; Lee, BH; Lee, DH; Lee, SH; Park, YS; Song, IS1
Bontem, P; Buderus, S; Iwańczak, B; Kalach, N; Koletzko, S; Liptay, S; Martínez-Gómez, MZ; Roma-Giannikou, E; Schwarzer, A; Urruzuno, P; Wenzl, TG1
Chen, A; Hsu, PI; Kuo, CH; Lai, KH; Tsay, FW; Tseng, HH; Wang, SW; Wu, DC1
Chiu, YC; Chuah, SK; Hsu, PI; Hu, ML; Hu, TH; Kuo, CM; Tai, WC; Wu, DC; Wu, KL1
Başer, O; Emer, O; Kadayifci, A; Kantarcioğlu, M; Kılcıler, G; Ozcan, A; Polat, Z; Uygun, A1
Wang, Z; Wu, S1
Barenys, M; Bory, F; Bujanda, L; Calvet, X; Calvo, MM; Castro-Fernández, M; García-Iglesias, P; Gisbert, JP; Lisozain, J; Sánchez-Delgado, J; Torra, S1
Georgopoulos, S; Karatapanis, S; Laoudi, F; Lisgos, P; Papantoniou, N; Papastergiou, V; Spiliadi, C; Xirouchakis, E1
Ashida, C; Higashida, A; Kuwada, T; Mamori, S; Mitsuoka, T; Senda, E; Suga, Y; Taki, M; Yamada, H1
Georgopoulos, SD; Laoudi, F; Martinez-Gonzalez, B; Mentis, AF; Sgouras, DN; Spiliadi, C; Xirouchakis, E1
Jo, HJ; Kim, MS; Kim, N; Kim, SE; Lee, DH; Park, YS; Shin, CM1
But, DY; Hsu, AS; Hung, IF; Lam, FY; Leung, WK; Liu, KS; Seto, WK; Tong, T; Wong, SY1
Graham, DY; Hsu, PI; Wang, WM; Wu, DC; Wu, JY1
Angueira, T; Ariño, I; Balboa, A; Barrio, J; Bermejo, F; Botargues-Bote, JM; Gisbert, JP; Gomez-Camarero, J; Gomez-Rodriguez, BJ; Herranz-Bachiller, MT; Huerta, A; Lucendo, AJ; Martin-Noguerol, E; McNicholl, AG; Modolell, I; Molina-Infante, J; O'Morain, C; Perez-Aisa, A; Rodriguez-Tellez, M1
Cho, KB; Heo, J; Jang, BI; Jeon, SW; Jung, JT; Kim, HS; Kwon, JG; Lee, DW; Lee, SH; Park, JB; Park, KS; Yang, CH1
Chiou, SS; Chiu, CH; Chiu, YC; Chuah, SK; Hu, ML; Hu, TH; Kuo, CH; Kuo, CM; Kuo, YH; Lee, CH; Liang, CM; Lu, LS; Tai, WC; Wu, KL; Yen, YH1
Dechsukhum, C; Kaewpitoon, N; Kaewpitoon, S; Leeanansaksiri, W; Loyd, RA; Matrakool, L; Panpimanmas, S; Tongtawee, T1
Hwang, JJ; Kim, N; Lee, AR; Lee, DH; Park, YS; Shin, CM; Yoon, H1
Georgopoulos, SD; Karatapanis, S; Papastergiou, V1
Choi, YJ; Kim, N; Kwon, YH; Lee, DH; Lee, JW; Lee, JY; Nam, RH; Suh, JH; Yoon, K1
Bai, P; He, L; Song, Z; Xue, Y; Zhang, J; Zhou, L1
Niv, Y1
Forte, A; Jeverica, S; Šeruga, M; Stefanovič, M; Tepeš, B; Vujasinović, M1
Aksoy Gökmen, A; Girginkardeşler, N; Kilimcioğlu, AA; Özbilgin, A; Şirin, MC1
Amorena, E; Campillo, A; Kutz, M; LaIglesia, M; Ostiz, M1
Georgopoulos, SD; Grivas, E; Kasapidis, P; Laoudi, F; Martinez-Gonzales, B; Mentis, A; Michopoulos, S; Petraki, K; Sgouras, D; Sotiropoulou, M; Spiliadi, C; Xirouchakis, E; Zampeli, E; Zografos, K1
Chang, KC; Chiou, SS; Chiu, YC; Chou, YP; Chuah, SK; Hu, ML; Hu, TH; Kuo, CH; Kuo, CM; Lee, CH; Liang, CM; Lu, LS; Tai, WC; Wu, KL1
Hayakawa, Y; Hirata, Y; Koike, K; Sakitani, K; Serizawa, T; Shichijo, S; Suzuki, N; Yamada, A1
Eguchi, T; Fujita, M; Fukuchi, T; Hashimura, H; Kanamori, A; Kano, C; Koizumi, A; Matsumoto, K; Momose, K; Okada, A; Shimoyama, K; Tsujimae, M; Yamashita, H1
Algaba, A; Barrio, J; Calvet, X; Castro, M; Gisbert, JP; González-Santiago, JM; Herranz, MT; Molina-Infante, J; Puig, I1
Alvaro, D; Bellesia, A; Brambilla, G; Bresci, G; D'Angelo, A; De Francesco, V; Di Ciaula, A; Eramo, A; Londoni, C; Manta, R; Portincasa, P; Ridola, L; Sacco, R; Scaccianoce, G; Tanzilli, A; Vassallo, R; Zullo, A1
Chiba, D; Chinda, D; Fukuda, S; Kikuchi, H; Mikami, T; Nakagawa, S; Nakamura, M; Sawaya, M; Shimoyama, T1
Adachi, T; Asakuma, Y; Kamata, K; Kashida, H; Komeda, Y; Kono, M; Kudo, M; Matsui, S; Minaga, K; Nagai, T; Nishida, N; Okamoto, A; Okamoto, K; Sakurai, T; Takenaka, M; Watanabe, T; Yamada, M; Yamao, K1
Fiorini, G; Gatta, L; Pavoni, M; Saracino, IM; Vaira, D; Zullo, A1
Carli, T; Kaliterna, N; Pintar, T1
Chen, Q; Liang, X; Liu, W; Long, X; Lu, H; Yu, L1
Bair, MJ; Chang, CC; Chang, CY; Chen, CC; Chen, MJ; Chen, PY; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Lee, JY; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Wu, MS; Yang, TH1
Irie, K; Kaneko, H; Kondo, M; Maeda, S; Sasaki, T; Shibata, W; Sue, S1
Dávila, I; Gómez-Cardeñosa, A; Lázaro-Sastre, M; Moreno-Rodilla, E; Muñoz-Bellido, FJ; Sobrino-García, M1
Kim, JM; Kim, N; Lee, DH; Lee, JW; Lee, SM; Nam, RH; Soo In, C1
Kim, N; Yoon, K1
De Francesco, V1
Chen, Q; Chen, Y; Gao, H; Graham, DY; Ji, Y; Li, D; Liang, X; Liu, M; Liu, W; Long, X; Lu, H; Song, Y; Sun, Y; Xu, B; Xu, G; Yu, L; Zhang, W; Zhao, Y1
Jin, Z; Li, Y; Lin, D; Lin, L; Meng, F; Pan, J; Shi, Z; Wu, J; Yang, N; Zhang, J; Zhou, Q1
Pan, L; Tang, G; Tang, Y; Wei, Z; Zhou, S; Zhu, H1
Cho, SJ; Choi, J; Chung, H; Chung, SJ; Kim, JL; Kim, SG; Lee, A1
Bozic, J; Kardum, G; Mestrovic, A; Pavicic Ivelja, M; Perkovic, N; Puljiz, Z; Tonkic, A; Vukovic, J1
Chen, W; Dzika, E; Lepczyńska, M; Lu, CY1
Li, CL; Lu, HP; Ren, XL; Song, ZQ; Suo, BJ; Tian, XL; Yao, XY; Zhang, H; Zhang, YX; Zhou, LY1
Bair, MJ; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chiu, MC; Chou, CK; El-Omar, EM; Fang, YJ; Hsu, YC; Hu, WH; Jiang, XT; Kuo, CC; Lee, JY; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tsai, MH; Tseng, CH; Wu, MS; Yang, TH; Yu, CC1
Chen, J; Gui, Q; Liang, X; Lu, H; Su, W; Yu, D; Zhang, W; Zhu, C1
Chen, JN; Ding, ZH; Huang, Y; Liang, X; Lu, H; Luo, LS; Zhang, W1
Li, C; Lu, H; Ren, X; Song, Z; Suo, B; Tian, X; Yao, X; Zhang, H; Zhang, Y; Zhou, L1
Chen, J; Ding, Z; Guo, Y; Han, Y; Huang, Y; Liang, X; Lu, H; Wang, J; Xu, P1

Reviews

2 review(s) available for metronidazole and s 1743

ArticleYear
Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:15

    Topics: Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Stomach Neoplasms

2015
Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis.
    Digestion, 2016, Volume: 93, Issue:2

    Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline

2016

Trials

47 trial(s) available for metronidazole and s 1743

ArticleYear
One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 2003, Jun-01, Volume: 17, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome

2003
Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance.
    Alimentary pharmacology & therapeutics, 2003, Oct-15, Volume: 18, Issue:8

    Topics: Adult; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome

2003
High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Hypersensitivity; Drug Therapy, Combination; Duodenal Ulcer; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Tetracycline; Treatment Outcome

2005
Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Chinese journal of digestive diseases, 2005, Volume: 6, Issue:4

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors

2005
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
    Helicobacter, 2006, Volume: 11, Issue:1

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome

2006
Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.
    Helicobacter, 2006, Volume: 11, Issue:1

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Patient Compliance; Quinolines; Tetracycline; Treatment Outcome

2006
Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly.
    Helicobacter, 2006, Volume: 11, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Male; Metronidazole; Nausea; Organometallic Compounds; Patient Compliance; Prospective Studies; Tetracycline

2006
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
    Alimentary pharmacology & therapeutics, 2006, Jul-15, Volume: 24, Issue:2

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Rifabutin; Treatment Outcome

2006
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
    The American journal of gastroenterology, 2006, Volume: 101, Issue:9

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome

2006
Randomized comparison of two rescue therapies for Helicobacter pylori infection.
    European journal of clinical investigation, 2006, Volume: 36, Issue:11

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline

2006
Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
    Helicobacter, 2007, Volume: 12, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Patient Compliance; Quinolines; Tetracycline

2007
One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin.
    Helicobacter, 2008, Volume: 13, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Aza Compounds; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Mixed Function Oxygenases; Moxifloxacin; Polymorphism, Restriction Fragment Length; Prospective Studies; Quinolines; Rifabutin

2008
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:5

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Organometallic Compounds; Prospective Studies; Salvage Therapy; Tetracycline; Treatment Outcome; Young Adult

2009
Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea.
    Helicobacter, 2010, Volume: 15, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Republic of Korea; Tetracycline; Time Factors; Treatment Outcome

2010
New effective treatment regimen for children infected with a double-resistant Helicobacter pylori strain.
    Journal of pediatric gastroenterology and nutrition, 2011, Volume: 52, Issue:4

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Europe; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lost to Follow-Up; Male; Medication Adherence; Metronidazole; Microbial Sensitivity Tests

2011
Helicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies.
    Medicine, 2011, Volume: 90, Issue:3

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Polymorphism, Genetic; Tetracycline; Treatment Outcome

2011
Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori.
    The American journal of the medical sciences, 2011, Volume: 342, Issue:3

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome

2011
Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2012, Volume: 23, Issue:1

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antidiarrheals; Bismuth; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline; Young Adult

2012
Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
    Singapore medical journal, 2012, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Doxycycline; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Tetracycline; Treatment Outcome; Young Adult

2012
Nonbismuth quadruple "concomitant" therapy versus standard triple therapy, both of the duration of 10 days, for first-line H. pylori eradication: a randomized trial.
    Journal of clinical gastroenterology, 2013, Volume: 47, Issue:3

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome; Urea

2013
Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
    Helicobacter, 2013, Volume: 18, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Young Adult

2013
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.
    BMC gastroenterology, 2013, Sep-19, Volume: 13

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Disease-Free Survival; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Peptic Ulcer; Quinolines; Recurrence; Stomach Neoplasms; Tetracycline; Treatment Outcome

2013
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial.
    Gut, 2014, Volume: 63, Issue:9

    Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Breath Tests; China; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline; Treatment Outcome

2014
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate.
    Helicobacter, 2014, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Young Adult

2014
Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study.
    Alimentary pharmacology & therapeutics, 2015, Volume: 41, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Young Adult

2015
Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.
    Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:9

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome

2015
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori Eradication.
    BioMed research international, 2015, Volume: 2015

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged

2015
Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
    Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:12

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus delbrueckii; Male; Metronidazole; Middle Aged; Probiotics; Prognosis; Prospective Studies; Streptococcus; Young Adult

2015
Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study.
    Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Tertiary Care Centers; Tetracycline; Young Adult

2016
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
    European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:6

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome; Young Adult

2016
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
    European journal of internal medicine, 2016, Volume: 32

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyloric Antrum; Urea

2016
A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication.
    Medicine, 2016, Volume: 95, Issue:19

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome

2016
Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infection.
    International journal of clinical practice, 2017, Volume: 71, Issue:9

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome

2017
Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori.
    Oncology, 2017, Volume: 93 Suppl 1

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies

2017
Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance.
    Helicobacter, 2018, Volume: 23, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; China; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Treatment Outcome

2018
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.
    Gastroenterology, 2018, Volume: 155, Issue:4

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Breath Tests; Clarithromycin; Clinical Decision-Making; Doxycycline; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Predictive Value of Tests; Proton Pump Inhibitors; Taiwan; Tetracycline; Time Factors; Treatment Outcome

2018
Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori.
    Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:4

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sulfonamides; Treatment Failure; Treatment Outcome

2019
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment.
    Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:11

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Young Adult

2019
Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial.
    Frontiers of medicine, 2020, Volume: 14, Issue:1

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; China; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome

2020
Empiric Versus Clarithromycin Resistance-Guided Therapy for Helicobacter pylori Based on Polymerase Chain Reaction Results in Patients With Gastric Neoplasms or Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Randomized Controlled Trial.
    Clinical and translational gastroenterology, 2020, Volume: 11, Issue:9

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Republic of Korea; RNA, Ribosomal, 23S; Stomach Neoplasms; Tetracycline; Treatment Outcome

2020
Randomised clinical trial comparing concomitant and hybrid therapy for eradication of Helicobacter pylori infection.
    PloS one, 2020, Volume: 15, Issue:12

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Croatia; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome

2020
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.
    Helicobacter, 2023, Volume: 28, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Tetracycline

2023
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
    The lancet. Gastroenterology & hepatology, 2023, Volume: 8, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Australia; Bismuth; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; RNA, Ribosomal, 16S; Young Adult

2023
Intravenous metronidazole-, levofloxacin-containing triple therapy for treating patients with Helicobacter pylori-related active peptic ulcer complications: A pilot study.
    Helicobacter, 2023, Volume: 28, Issue:2

    Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Peptic Ulcer; Pilot Projects

2023
A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment.
    The Journal of antimicrobial chemotherapy, 2023, 03-02, Volume: 78, Issue:3

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome

2023
Bismuth, esomeprazole, metronidazole, and minocycline or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.
    Chinese medical journal, 2023, 04-20, Volume: 136, Issue:8

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Minocycline; Potassium Citrate; Tetracycline

2023
Rifabutin-Containing Triple Therapy Versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial.
    The Journal of infectious diseases, 2023, 08-31, Volume: 228, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Rifabutin; Treatment Outcome

2023

Other Studies

21 other study(ies) available for metronidazole and s 1743

ArticleYear
Helicobacter pylori infection in Greenlandic patients with dyspepsia.
    International journal of circumpolar health, 2004, Volume: 63 Suppl 2

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Dyspepsia; Esomeprazole; Greenland; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole

2004
Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children.
    Journal of pediatric gastroenterology and nutrition, 2006, Volume: 43, Issue:2

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Patient Compliance; Prospective Studies; Treatment Outcome

2006
Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
    The American journal of geriatric pharmacotherapy, 2007, Volume: 5, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Merkel Cell; Clostridioides difficile; Cytotoxins; Diarrhea; Ear Neoplasms; Enterocolitis, Pseudomembranous; Esomeprazole; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Male; Metronidazole; Ofloxacin; Skin Neoplasms; Thyroxine; Vancomycin

2007
High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates.
    Alimentary pharmacology & therapeutics, 2012, Volume: 36, Issue:2

    Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged

2012
Effectiveness of esomeprazole-based triple therapy of H. pylori in young patients in Japan.
    Scandinavian journal of gastroenterology, 2013, Volume: 48, Issue:1

    Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Esomeprazole; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Middle Aged

2013
Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
    World journal of gastroenterology, 2015, Jul-14, Volume: 21, Issue:26

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medical Records; Medication Adherence; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors; Rabeprazole; Remission Induction; Retrospective Studies; Tetracycline; Time Factors; Treatment Outcome

2015
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:5

    Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Retreatment; Treatment Outcome

2016
[In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
    Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antitrichomonal Agents; Cryopreservation; Drug Resistance; Esomeprazole; Humans; Metronidazole; Ornidazole; Pantoprazole; Parasitic Sensitivity Tests; Proton Pump Inhibitors; Time Factors; Trichomonas vaginalis

2016
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection].
    Gastroenterologia y hepatologia, 2016, Volume: 39, Issue:9

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Spain; Stomach Ulcer

2016
Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 51

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome

2016
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.
    Digestion, 2016, Volume: 94, Issue:4

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome

2016
Bismuth-based quadruple therapy following H. pylori eradication failures: a multicenter study in clinical practice.
    Journal of gastrointestinal and liver diseases : JGLD, 2017, Volume: 26, Issue:3

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bismuth; Capsules; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Italy; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Tablets; Tetracycline; Time Factors; Treatment Failure

2017
The Resolution of Helicobacter suis-associated Gastric Lesions after Eradication Therapy.
    Internal medicine (Tokyo, Japan), 2018, Jan-15, Volume: 57, Issue:2

    Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Esomeprazole; Gastric Mucosa; Helicobacter heilmannii; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction

2018
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
    European journal of gastroenterology & hepatology, 2018, Volume: 30, Issue:6

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors; Tinidazole; Treatment Outcome

2018
The need for a patient-tailored Helicobacter pylori eradication protocol prior to bariatric surgery.
    The Journal of international medical research, 2018, Volume: 46, Issue:7

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bariatric Surgery; Body Mass Index; Clinical Protocols; Drug Therapy, Combination; Esomeprazole; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Obesity, Morbid; Precision Medicine; Preoperative Care; Retrospective Studies; Young Adult

2018
A case report of fixed drug eruption caused by several drugs because of cross-reactivity and co-sensitization.
    Contact dermatitis, 2019, Volume: 80, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Cross Reactions; Drug Eruptions; Esomeprazole; Humans; Levofloxacin; Male; Metronidazole; Proton Pump Inhibitors; Recurrence

2019
Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
    Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:4

    Topics: Anti-Bacterial Agents; Bismuth; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Risk Factors; Tetracycline; Treatment Failure

2019
[Eradication Rates of 10-day Sequential Therapy for
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2019, Feb-25, Volume: 73, Issue:2

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Republic of Korea; Tertiary Care Centers; Treatment Outcome

2019
A novel hybrid first-line therapy for H. pylori eradication: results of a pilot study.
    Journal of gastrointestinal and liver diseases : JGLD, 2019, Volume: 28, Issue:1

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors; Treatment Outcome

2019
Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China.
    Scientific reports, 2020, 09-21, Volume: 10, Issue:1

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies

2020
Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro.
    Clinical and translational gastroenterology, 2021, 04-09, Volume: 12, Issue:4

    Topics: Anti-Infective Agents; Blastocystis; Candida albicans; Enterococcus faecium; Escherichia coli; Esomeprazole; Gastrointestinal Microbiome; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lacticaseibacillus rhamnosus; Metronidazole; Microbial Sensitivity Tests; Pantoprazole; Proton Pump Inhibitors

2021